EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies

Jindong Xie iD, Manqing Liu iD, Xinpei Deng iD, Yuhui Tang iD, Shaoquan Zheng iD, Xueqi Ou iD, Hailin Tang iD, Xiaoming Xie iD, Minqing Wu iD, Yutian Zou iD

iMeta · 2024-02 · 3 (1)

DOI: 10.1002/imt2.156 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift iMeta, 2024-01. Verfasst von Jindong Xie und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer Sun Yat-sen University Cancer Center Guangz…. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microbiota is essential for maintaining local and systemic immune homeostasis in the presence of bacterial challenges. It has been demonstrated that microbiota play contrasting roles in cancer development as well as anticancer immunity. Cancer immunotherapy, a novel anticancer therapy that relies on the stimulation of host immunity, has suffered from a low responding rate and incidence of severe immune‐related adverse events (irAEs). Previous studies have demonstrated that the diversity and composition of gut microbiota were associated with the heterogeneity of therapeutic effects. Therefore, alteration in microbiota taxa can lead to improved clinical outcomes in immunotherapy. In this review, we determine whether microbiota composition or microbiota‐derived metabolites are linked to responses to immunotherapy and irAEs. Moreover, we discuss various approaches to improve immunotherapy efficacy or reduce toxicities by modulating microbiota composition.

Schlagwörter

Stichwörter der Autor:innen

cancergut microbiotaimmune‐related adverse eventsimmunotherapyprecision medicinepredominant bacteria

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer Sun Yat-sen University Cancer Center Guangzhou China.
  • Hospital of Stomatology, Guanghua School of Stomatology, Guangdong Provincial Key Laboratory of Stomatology Sun Yat-sen University Guangzhou China.
  • Department of Breast Surgery, Breast Disease Center, The First Affiliated Hospital Sun Yat-sen University Guangzhou China.

ORCID-Profile: Jindong Xie, Manqing Liu, Xinpei Deng, Yuhui Tang, Shaoquan Zheng, Xueqi Ou, Hailin Tang, Xiaoming Xie, Minqing Wu, Yutian Zou

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xie, J., Liu, M., Deng, X., Tang, Y., Zheng, S., Ou, X., Tang, H., Xie, X., Wu, M., & Zou, Y. (2024). Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies. iMeta, 3(1). https://doi.org/10.1002/imt2.156

Vancouver

Xie J, Liu M, Deng X, Tang Y, Zheng S, Ou X, et al. Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies. iMeta. 2024;3(1). doi:10.1002/imt2.156

BibTeX
@article{Xie2024,
  author = {Xie, Jindong and Liu, Manqing and Deng, Xinpei and Tang, Yuhui and Zheng, Shaoquan and Ou, Xueqi and Tang, Hailin and Xie, Xiaoming and Wu, Minqing and Zou, Yutian},
  title = {Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies},
  journal = {iMeta},
  year = {2024},
  volume = {3},
  number = {1},
  doi = {10.1002/imt2.156}
}
Kostenlos starten →